Clinical Research of Diquas ophthalmic solution 3% on corneal epithelial barrier function in dry eye
Not Applicable
- Conditions
- Dry eye
- Registration Number
- JPRN-UMIN000021884
- Lead Sponsor
- Collaborative joint clinical research organized with Kyorin university School of Medicine and Santen Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of allergy to fluorescein Patients who have allergic conjunctivitis, and have possibilities to get worse during study phase. Experience in using Diquas ophthalmic solution 3%. The investigator or subinvestigator has judged that the patient is ineligible as study subject.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method